The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review - Wikidata - awgldk - TriplyDB

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

http://www.wikidata.org/entity/Q34566213

about

How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer Molecular imaging of breast cancer: present and future directions Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI.Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients.Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL.Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients.Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy.Role of imaging in neoadjuvant therapy for breast cancer.Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy.Intravoxel incoherent motion (IVIM) histogram biomarkers for prediction of neoadjuvant treatment response in breast cancer patients.Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging Ultrasonography-guided surgical clip placement for tumor localization in patients undergoing neoadjuvant chemotherapy for breast cancer.Applying a new quantitative global breast MRI feature analysis scheme to assess tumor response to chemotherapy.Diffusion-weighted MR imaging in prediction of response to neoadjuvant chemotherapy in patients with breast cancer.Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study.Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis.Potential Clinical Applications of 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer.Hybrid 18F-FDG PET/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy.MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer.Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer.Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.Magnetic resonance imaging patterns of tumor regression in breast cancer patients after neo-adjuvant chemotherapy, and an analysis of the influencing factors.Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype.MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.Comprehensive breast MRI: an update.Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers

P2860

Q26798419-065DF7A4-FC3E-416C-A622-EB21D6334FB0 Q26999488-B42D08E4-B753-40C1-A98A-C8BBF832D33C Q27027281-92F6898F-AB47-41A9-835E-C35DB8BA3F1A Q34042627-6C7B8864-C21C-4370-8D91-BE6A515F0CA0 Q35649202-7B49579A-0024-47B2-B05B-833F37A25A1F Q35947118-412E3A47-FFBE-4FDB-98C6-0445C9DA2DCB Q36762742-5EE1858D-32B7-44FD-8831-40D446DF50C8 Q36779852-21A1CB86-48EB-4581-A62F-F5EF20C6DCEB Q37558516-3B00A4C4-914D-497D-A196-F7B524EB4BDF Q37624053-CE7DA329-5F7B-4B2F-A173-3E6608289411 Q37746960-75FEA0AE-24D4-4858-81A7-F9FB2321DA8B Q38250247-0445D702-05E2-4FDC-8567-C755EBDC8ED6 Q38366386-F612CECF-4C5C-409D-8941-8FDC9CB8C51E Q38407471-129BE3D4-9DE8-4C53-9C73-8456320C907E Q38601265-F271BA6A-8FCC-4FFF-B6F8-8D7E96543358 Q41276299-E2E8555C-B7B9-4821-9A72-4C17B73EAAA2 Q41827930-00239E00-3497-45EF-8E2C-F2683CA38141 Q42663270-D63BE014-AA14-448E-804D-7063757E6AAB Q45349563-66599C7F-7AA9-4EC4-83A6-6CA2007CC90E Q47188638-CAFFD2FC-ED80-4204-885E-2F3D217E6C4C Q47287018-9D827277-F39A-418F-BEE5-F088F15CDC77 Q47961966-F4A73260-9AC5-4281-A50F-BC11758045EF Q48297177-8ED76726-150E-49DE-9014-C41A4AF733ED Q50052437-58B7F0AC-9C62-4616-92E6-79B0E8C39F1C Q50060384-BD7CFD88-A78E-43F8-96C7-D80222CF4F86 Q52984715-A986E2EB-EABA-4AE5-B301-88DC269B79DF Q53364770-01CB1AED-E080-4399-AB7D-76CA11D8CF39 Q55003756-B0C92EB9-479C-48C3-B398-417471FBF8F8 Q55361006-348E98E1-73A3-4754-AF6B-33C4B9BA63E0 Q55640448-141F1BBE-12C2-44B4-8C05-59123E401BEE Q57816466-D75AB829-C0D9-4179-9A25-62CC2FF7569F

P2860

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

http://www.wikidata.org/entity/Q34566213

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The role of magnetic resonance ...... motherapy: a systematic review

@ast

The role of magnetic resonance ...... motherapy: a systematic review

@en

The role of magnetic resonance ...... motherapy: a systematic review

@nl

type

label

The role of magnetic resonance ...... motherapy: a systematic review

@ast

The role of magnetic resonance ...... motherapy: a systematic review

@en

The role of magnetic resonance ...... motherapy: a systematic review

@nl

prefLabel

The role of magnetic resonance ...... motherapy: a systematic review

@ast

The role of magnetic resonance ...... motherapy: a systematic review

@en

The role of magnetic resonance ...... motherapy: a systematic review

@nl

P1433

Q34566213-457708F1-8392-415C-B9B5-9D3C67AABEFC

P1476

Q34566213-EB7DBFEB-BFEB-4556-8AF6-1DB0DC23E8C5

P2093

Q34566213-13F32C47-D80C-4250-9315-8642BAD44712

Q34566213-5016A6E3-AD63-45DF-B315-1CDA5ABC6F7D

Q34566213-532631CF-38F9-4872-9EA8-27BE4C50922B

Q34566213-A41FA516-94FB-4EDD-9E4A-65AB975A7B1A

Q34566213-C649AF69-8EEC-438C-8A1C-9E8781C7604E

Q34566213-CCA3A14E-4B7E-44AF-9C86-F49CBA56A071

Q34566213-D05718D2-9DB4-4038-A7B9-CA9F3BB3007A

Q34566213-D982BF7C-E382-4763-94AE-A484996ADDEE

P2860

Q34566213-03010ECC-F14F-43FF-B121-6C9668BB8A10

Q34566213-06306108-27A8-4E15-BDD2-5A1C203AB031

Q34566213-0C4EC918-5E0F-42CB-8774-A0750C291FBF

Q34566213-0C808204-0660-4568-9546-6A71A895C1C0

Q34566213-12EABD3E-5003-4005-BA6D-24746EF8F855

Q34566213-16093058-7E82-4928-A788-DC2CB797D4B5

Q34566213-174C1284-2191-4156-B114-305DDC4BF983

Q34566213-1892F8DA-2143-4F55-A7A2-4B4194187508

Q34566213-40915AF6-F8FA-4333-803A-FD0E62B96C6A

Q34566213-47911A89-6F57-4263-AE18-C5A0BC2E98AF

P2888

Q34566213-3A2561AB-73CC-4CBC-A0F3-76562D66D18C

P304

Q34566213-421CD0CB-C8A3-4B75-AE00-4B282DF8F265

P31

Q34566213-E758B990-86C3-47FB-AA20-95400E8FD1DB

P356

Q34566213-222DB920-12F9-48A9-9BF0-D169F09A3716

P433

Q34566213-D0AC67D4-7DB7-4BF2-8579-B4D5D8B1FC18

P478

Q34566213-BD1AD92D-1FD4-4E58-B480-2AABEF24498B

P577

Q34566213-791581D8-C134-4207-86FF-36C41BBB191C

P5875

Q34566213-C493A9AA-01F7-44D7-AF1D-BE80E9B377A5

P6179

Q34566213-543B4A98-08C2-4BFD-8C63-6F2C35C86682

P698

Q34566213-087BF882-4AA0-42A0-B659-3B16EA86FB63

P921

Q34566213-168E5320-0AC0-425B-8E1D-D7F6F959D735

Q34566213-409CFC3D-02C6-48B2-9DD7-09383C8600D9

P932

Q34566213-5624004B-8638-4B02-91F7-51D0996EAA5E

P356

S13244-013-0219-Y

P1433

Insights into imaging

P1476

The role of magnetic resonance ...... motherapy: a systematic review

@en

P2093

J E Wildberger

http://www.w3.org/2001/XMLSchema#string

M B I Lobbes

http://www.w3.org/2001/XMLSchema#string

M Smidt

http://www.w3.org/2001/XMLSchema#string

M van Goethem

http://www.w3.org/2001/XMLSchema#string

R G Beets-Tan

http://www.w3.org/2001/XMLSchema#string

R Prevos

http://www.w3.org/2001/XMLSchema#string

R Schipper

http://www.w3.org/2001/XMLSchema#string

V C G Tjan-Heijnen

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy

Overview of resistance to systemic therapy in patients with breast cancer.

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging.

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.

Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy.

Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer.

P2888

s13244-013-0219-y

P304

163-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13244-013-0219-Y

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235380679

http://www.w3.org/2001/XMLSchema#string

P6179

1040178702

http://www.w3.org/2001/XMLSchema#string

P698

23359240

http://www.w3.org/2001/XMLSchema#string

P921

P932

3609956

http://www.w3.org/2001/XMLSchema#string